The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 3, 2008, Pages 427-432

  Tsuda, Aiko ^a   Fujiyama, Junshin ^a   Miki, Akiko ^b   Hori, Satoko ^b   Ohtani, Hisakazu ^b   Sawada, Yasufumi ^b  

^a Gamou Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adverse event; Drug interaction; Phenytoin; TS 1

Indexed keywords

CLONAZEPAM; PHENYTOIN; PYRIMIDINE ANTAGONIST; TEGAFUR PLUS GIMERACIL PLUS OTERACIL POTASSIUM; TS 1;

AGED; ARTICLE; BLOOD SAMPLING; CANCER THERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DIZZINESS; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE INCREASE; DRUG INFORMATION; DRUG INTOXICATION; DRUG MONITORING; DRUG WITHDRAWAL; FALLING; HUMAN; MALE; MEDICAL LITERATURE; MEDLINE; MYOCLONUS SEIZURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT REFUSAL; WALKING;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG COMBINATIONS; DRUG INTERACTIONS; HUMANS; MALE; OXONIC ACID; PHENYTOIN; PYRIDINES; TEGAFUR;

EID: 45849083173     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0621-6     Document Type: Article

References (22)

1. Afsar A, Lee C, Riddick DS (1996) Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil. Can J Physiol Pharmacol 74:150-156
2. Brickell K, Porter D, Thompson P (2003) Phenytoin toxicity fluoropyrimidines (5FU/capecitabine): three case reports. Br J Cancer 89:615-616
3. Ethical Drug package insert of Futraful capsule (Taiho Pharmaceutical Co., Ltd., Tokyo, Japan)
4. Fukami T, Nakajima M, Higashi E, Yamanaka H, Sakai H, McLeod HL, Yokoi T (2005) Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity. Drug Metab Dispos 33:1202-1210
5. Gilbar PJ, Brodribb TR (2001) Phenytoin and fluorouracil interaction. Ann Pharmacother 35:1367-1370
6. Hara T, Ichinomiya A, Matsushima M et al (1992) A case of acute phenytoin toxicity associated with antitumor drug tegafur. Kyushu J Neuropsychiatry 38:36-41 (in Japanese)
7. Harada H, Rin E, Sato T (1990) Acute phenytoin toxicity due to drug interaction with antitumor drug 5-FU. J Tottori Med Assoc 18:197-199 (in Japanese)
8. Ikeda M, Furukawa H, Imamura H et al (2002) Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function. Cancer Chemother Pharmacol 50:25-32
9. Konishi H, Morita K, Minouchi T et al (2002) Probable metabolic interaction of doxifluridine with phenytoin. Ann Pharmacother 36:831-834
10. Loscher W (2007) Drug transporters in the epileptic brain. Epilepsia 48(Suppl)1:8-13
11. Mann MW, Pons G (2007) Various pharmacogenetic aspects of antiepileptic drugtherapy. CNS Drugs 21(2):143-164
12. Nakai S, Yanai I (2000) Two cases of acute phenytoin toxicity probably due to drug interactions with antitumor drugs. Jpn J Clin Psychiatry 29:413-417 (in Japanese)
13. Park JY, Kim KA (2003) Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes. Eur Clin Pharmacol 59:407-409
14. Richens A (1979) Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet 4(3):153-169
15. Rosemergy I, Findlay M (2002) Phenytoin toxicity as a result of 5-fluorouracil administration. N Z Med J 115:U124
16. Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Okabe H, Oyama K, Takeda S, Unemi N, Fukushima M (1996) Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 56:2602-2606
17. Stupans I, Richards DA, McClure MT (1995) Effects of 5-fluorouracil treatment on rat liver microsomal enzymes. Xenobiotica 25:1-8
18. Taguchi T, Inuyama Y, Kanamaru R, Hasegawa K, Akazawa S, Niitani H, Furue H, Kurihara M, Ota K, Suga S, Ariyoshi Y, Takai S, Shimoyama T, Toge T, Takashima S, Sugimachi K, Hara Y, Fujita H, Kimura K, Saito T, Tsukagoshi S, Nakao I (1997) Phase I study of S-1. S-1 study group Gan To Kagaku Ryoho 34(15):2253-2264
19. Tsuchishita Y, Hori T, Kameda T, Fujimura Y, Kusumoto M (2007) A case of therapeutic drug monitoring (TDM) of phenytoin during oral treatment with tegafur. Jpn J Ther Drug Monit 24(1):47-50 (in Japanese)
20. Wakisaka S, Shimauchi M, Kaji Y, Nonaka A, Kinoshita K (1990) Acute phenytoin toxicity associated with the antineoplastic agent UFT. Fukuoka Igaku Zasshi 81:192-196 (in Japanese)
21. Yamamoto K, Shirakawa O, Nishiguchi N, Maeda K (2000) A case of phenytoin toxicity due to the combination treatment with tegafur. Jpn J Clin Psychopharmacol 3:263-266 (in Japanese)
22. Yokoyama F, Nagao M, Aikawa H et al (1994) A case of acute phenytoin toxicity associated with the antitumor agent UFT. Bull Tokyo Psychiatr Assoc 1(12):49-53 (in Japanese)